J E Mok

420 total citations
27 papers, 342 citations indexed

About

J E Mok is a scholar working on Reproductive Medicine, Molecular Biology and Obstetrics and Gynecology. According to data from OpenAlex, J E Mok has authored 27 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Reproductive Medicine, 9 papers in Molecular Biology and 7 papers in Obstetrics and Gynecology. Recurrent topics in J E Mok's work include Endometrial and Cervical Cancer Treatments (7 papers), Ovarian cancer diagnosis and treatment (6 papers) and Extracellular vesicles in disease (3 papers). J E Mok is often cited by papers focused on Endometrial and Cervical Cancer Treatments (7 papers), Ovarian cancer diagnosis and treatment (6 papers) and Extracellular vesicles in disease (3 papers). J E Mok collaborates with scholars based in South Korea, Puerto Rico and United States. J E Mok's co-authors include Young Tae Kim, Joshua T Vogelstein, Rong Wu, Denise C. Connolly, R.Y. Lei, K. V. Shah, Kathleen R. Cho, F. Xavier Bosch, Núbia Muñóz and David L. Greenspan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biomaterials and Scientific Reports.

In The Last Decade

J E Mok

25 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J E Mok South Korea 10 142 101 99 87 63 27 342
Zehra Ordulu United States 12 130 0.9× 195 1.9× 128 1.3× 199 2.3× 67 1.1× 36 559
Marcia A. Ciccone United States 13 91 0.6× 30 0.3× 124 1.3× 148 1.7× 86 1.4× 34 436
Elif Peştereli Türkiye 10 114 0.8× 27 0.3× 62 0.6× 68 0.8× 91 1.4× 28 442
M Abrate Italy 11 102 0.7× 26 0.3× 99 1.0× 132 1.5× 46 0.7× 25 368
E. Piazzola Italy 9 67 0.5× 101 1.0× 101 1.0× 90 1.0× 24 0.4× 12 364
S. Mancuso Italy 11 71 0.5× 23 0.2× 95 1.0× 176 2.0× 71 1.1× 22 399
M. J. Merino United States 9 72 0.5× 32 0.3× 58 0.6× 38 0.4× 68 1.1× 13 378
R RUNIC United States 8 104 0.7× 46 0.5× 125 1.3× 221 2.5× 13 0.2× 13 488
Meilian Dong China 10 121 0.9× 25 0.2× 39 0.4× 34 0.4× 41 0.7× 17 369
Sunayna Best United Kingdom 9 188 1.3× 332 3.3× 34 0.3× 54 0.6× 49 0.8× 17 541

Countries citing papers authored by J E Mok

Since Specialization
Citations

This map shows the geographic impact of J E Mok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J E Mok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J E Mok more than expected).

Fields of papers citing papers by J E Mok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J E Mok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J E Mok. The network helps show where J E Mok may publish in the future.

Co-authorship network of co-authors of J E Mok

This figure shows the co-authorship network connecting the top 25 collaborators of J E Mok. A scholar is included among the top collaborators of J E Mok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J E Mok. J E Mok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mok, J E, et al.. (2025). Comparative and pharmacological investigation of bEVs from eight Lactobacillales strains. Scientific Reports. 15(1). 27263–27263.
2.
Park, Jeong Hwan, et al.. (2025). Celecoxib Enhances Oxidative Muscle Fibre Formation and Improves Muscle Functions Through Prokr1 Activation in Mice. Journal of Cachexia Sarcopenia and Muscle. 16(1). e13704–e13704.
3.
Mok, J E, et al.. (2024). PROKR1–CREB–NR4A2 axis for oxidative muscle fiber specification and improvement of metabolic function. Proceedings of the National Academy of Sciences. 121(4). e2308960121–e2308960121. 2 indexed citations
4.
Mok, J E, et al.. (2023). Benzbromarone Induces Targeted Degradation of HSP47 Protein and Improves Hypertrophic Scar Formation. Journal of Investigative Dermatology. 144(3). 633–644. 6 indexed citations
5.
Mok, J E, Tatsuro Kanaki, Masato Horikawa, et al.. (2021). Cellhesion VP enhances the immunomodulating potential of human mesenchymal stem cell-derived extracellular vesicles. Biomaterials. 271. 120742–120742. 15 indexed citations
6.
Zhang, Chunjuan, et al.. (2021). PROKR1 delivery by cell-derived vesicles restores the myogenic potential of Prokr1-deficient C2C12 myoblasts. Nanomedicine Nanotechnology Biology and Medicine. 37. 102448–102448. 7 indexed citations
7.
Kim, Sung Woo, et al.. (2021). Dysregulation of the Acrosome Formation Network by 8-oxoguanine (8-oxoG) in Infertile Sperm: A Case Report with Advanced Techniques. International Journal of Molecular Sciences. 22(11). 5857–5857. 3 indexed citations
8.
Mok, J E, Tae Sub Park, Sunhong Kim, et al.. (2020). Prokineticin receptor 1 ameliorates insulin resistance in skeletal muscle. The FASEB Journal. 35(2). e21179–e21179. 14 indexed citations
9.
Mok, J E, et al.. (2012). Endoscopic comparison of esophageal and gastroduodenal mucosal effects of enterocoating alendronate with calcitriol combined drug and alendronate in Korean postmenopausal women. 15th International & 14th European Congress of Endocrinology. 29. 1 indexed citations
10.
Kim, Yong‐Hee, Yunlim Kim, Min Hyung Jung, et al.. (2006). Adult granulosa cell tumor of the ovary: 35 cases in a single Korean institute. Acta Obstetricia Et Gynecologica Scandinavica. 85(1). 112–115. 12 indexed citations
11.
Mok, J E, Min Hyung Jung, Kyung Rae Kim, et al.. (2006). Malignant mixed mullerian tumors of the ovary: experience with cytoreductive surgery and platinum-based combination chemotherapy. International Journal of Gynecological Cancer. 16(1). 101–105. 30 indexed citations
12.
Nam, J.H., et al.. (2006). Primary peritoneal carcinoma: experience with cytoreductive surgery and combination chemotherapy. International Journal of Gynecological Cancer. 16(1). 23–28. 10 indexed citations
13.
Joo, Won Duk, Dalyong Kim, Jin Hyoung Kim, et al.. (2004). 851 Prevalence of Human Papillomavirus Infection in Korean Women: Risks of Abnormal Pap Smear and Cervical Neoplasia. International Journal of Gynecological Cancer. 14. 234–234. 1 indexed citations
14.
Nam, JH, Sung Hoon Kim, J.-H. Kim, et al.. (2002). Nonradical treatment is as effective as radical surgery in the management of cervical cancer stage IA1. International Journal of Gynecological Cancer. 12(5). 480–484. 13 indexed citations
15.
Nam, JH, Sung Hoon Kim, J.-H. Kim, et al.. (2002). Nonradical treatment is as effective as radical surgery in the management of cervical cancer stage IA1. International Journal of Gynecological Cancer. 12(5). 480–484. 4 indexed citations
16.
Huh, Jooryung, et al.. (2001). The Expression of bcl-2 protein in Gestational Trophoblastic Disease and Chorionic Villi.. Korean Journal of Obstetrics & Gynecology. 41(9). 2386–2393. 1 indexed citations
17.
Mok, J E, et al.. (2001). Gynecologic Cancer Registry Program in Korean Women (Jan. 1. 1995 - Dec. 31. 1995 ).. Korean Journal of Obstetrics & Gynecology. 41(1). 253–293. 1 indexed citations
18.
Lee, Jeong Hoon, et al.. (1998). Localized in vivo 1H nuclear MR spectroscopy for evaluation of human uterine cervical carcinoma.. American Journal of Roentgenology. 170(5). 1279–1282. 35 indexed citations
19.
Greenspan, David L., Denise C. Connolly, Rong Wu, et al.. (1997). Loss of FHIT expression in cervical carcinoma cell lines and primary tumors.. PubMed. 57(21). 4692–8. 126 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zehra Ordulu Breakdown of academic impact, for papers by Marcia A. Ciccone Breakdown of academic impact, for papers by Elif Peştereli Breakdown of academic impact, for papers by M Abrate Breakdown of academic impact, for papers by E. Piazzola Breakdown of academic impact, for papers by S. Mancuso Breakdown of academic impact, for papers by M. J. Merino Breakdown of academic impact, for papers by R RUNIC Breakdown of academic impact, for papers by Meilian Dong Breakdown of academic impact, for papers by Sunayna Best
Rankless by CCL
2026